| Literature DB >> 24677741 |
Bill C Hawkins1, Lisa M Lindqvist, Duong Nhu, Phillip P Sharp, David Segal, Andrew K Powell, Michael Campbell, Eileen Ryan, Jennifer M Chambers, Jonathan M White, Mark A Rizzacasa, Guillaume Lessene, David C S Huang, Christopher J Burns.
Abstract
The complex natural products silvestrol (1) and episilvestrol (2) are inhibitors of translation initiation through binding to the DEAD-box helicase eukaryotic initiation factor 4A (eIF4A). Both compounds are potently cytotoxic to cancer cells in vitro, and 1 has demonstrated efficacy in vivo in several xenograft cancer models. Here we show that 2 has limited plasma membrane permeability and is metabolized in liver microsomes in a manner consistent with that reported for 1. In addition, we have prepared a series of analogues of these compounds where the complex pseudo-sugar at C6 has been replaced with chemically simpler moieties to improve drug-likeness. Selected compounds from this work possess excellent activity in biochemical and cellular translation assays with potent activity against leukemia cell lines.Entities:
Keywords: biological activity; drug discovery; silvestrol; structure-activity relationships; translation inhibitors
Mesh:
Substances:
Year: 2014 PMID: 24677741 DOI: 10.1002/cmdc.201400024
Source DB: PubMed Journal: ChemMedChem ISSN: 1860-7179 Impact factor: 3.466